Effect of Botulinum Toxin Injection on EMG Activity and Bite Force in Masticatory Muscle Disorder: A Randomized Clinical Trial
Botulinum toxin type A (BoNT-A) is increasingly used in treating masticatory muscle pain disorder; however, safe doses and reinjection intervals still need to be established. The purpose of this randomized clinical trial was to evaluate the degree and duration of the impairment of masticatory muscle...
Main Authors: | Victoria Sitnikova, Antti Kämppi, Olli Teronen, Pentti Kemppainen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/14/8/545 |
Similar Items
-
Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection
by: Jose-Francisco Montes-Carmona, et al.
Published: (2020-12-01) -
Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial
by: Giancarlo De la Torre Canales, et al.
Published: (2024-02-01) -
Effect of Botulinum Toxin on Masticatory Muscle Pain in Patients with Temporomandibular Disorders: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
by: So Ra Kim, et al.
Published: (2023-10-01) -
Efficacy of Botulinum Toxin Type-A I in the Improvement of Mandibular Motion and Muscle Sensibility in Myofascial Pain TMD Subjects: A Randomized Controlled Trial
by: Giancarlo De la Torre Canales, et al.
Published: (2022-06-01) -
Botulinum Toxin and Percutaneous Needle Electrolysis for the Treatment of Chronic Masticatory Myalgia
by: Luis-Miguel Gonzalez-Perez, et al.
Published: (2023-04-01)